AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Rating of "Buy" from Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) have earned a consensus recommendation of "Buy" from the five ratings firms that are presently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $13.40.

Several equities analysts have recently commented on AHCO shares. Wall Street Zen raised shares of AdaptHealth from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Truist Financial reduced their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Finally, Royal Bank Of Canada reduced their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th.

Insiders Place Their Bets

In related news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the sale, the director owned 50,045 shares in the company, valued at $486,937.85. This represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.55% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On AdaptHealth

Institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC raised its stake in AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after acquiring an additional 4,758 shares during the period. Oppenheimer Asset Management Inc. raised its stake in AdaptHealth by 6.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock worth $356,000 after acquiring an additional 2,081 shares during the period. New York State Teachers Retirement System increased its stake in shares of AdaptHealth by 3.3% in the first quarter. New York State Teachers Retirement System now owns 80,455 shares of the company's stock valued at $872,000 after purchasing an additional 2,600 shares during the period. Janus Henderson Group PLC increased its stake in shares of AdaptHealth by 42.9% in the fourth quarter. Janus Henderson Group PLC now owns 38,298 shares of the company's stock valued at $364,000 after purchasing an additional 11,500 shares during the period. Finally, Janney Montgomery Scott LLC acquired a new stake in shares of AdaptHealth in the first quarter valued at approximately $854,000. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Stock Up 3.3%

Shares of AHCO stock traded up $0.30 during trading hours on Wednesday, hitting $9.51. 1,368,605 shares of the company were exchanged, compared to its average volume of 1,404,448. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06. AdaptHealth has a one year low of $7.11 and a one year high of $11.70. The business's 50-day simple moving average is $9.33 and its two-hundred day simple moving average is $9.25. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 17.61, a P/E/G ratio of 1.02 and a beta of 1.59.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.